Literature DB >> 8380734

Signal transduction in c-met mediated motogenesis.

D L Faletto1, D R Kaplan, D O Halverson, E M Rosen, G F Vande Woude.   

Abstract

We have begun characterizing the signal transduction pathways used by the c-met receptor in cells in which ligand (HGF-SF) stimulates motogenesis in the absence of mitogenesis. Primary targets (within 10-15 minutes) were identified as PI-3 kinase, GAP, PLC gamma, src, and MAP kinase, substrates which are also activated upon growth factor activation of mitogenic receptor systems. Following HGF-SF treatment, the 85 kD subunit of PI-3 kinase is phosphorylated on tyrosine and PI-3 kinase activity rapidly associates with the c-met receptor. A number of these substrates are implicated in cytoskeletal rearrangements and may be important in the motogenic response to the factor. We have also identified a number of colon carcinoma lines which express unamplified levels of constitutively tyrosine phosphorylated c-met protein. In these and other (gastric) cell lines which express amplified levels of activated receptor protein, we have determined that receptor activation is not due to the autocrine production of ligand.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380734

Source DB:  PubMed          Journal:  EXS        ISSN: 1023-294X


  11 in total

1.  The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M Holgado-Madruga; I Royal; M A Naujokas; T M Fournier; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism.

Authors:  P Chen; H Xie; A Wells
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

3.  Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor.

Authors:  R Wang; R Kobayashi; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.

Authors:  M Jeffers; G A Taylor; K M Weidner; S Omura; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines.

Authors:  Y Nakayama; K Okazaki; K Shibao; T Sako; K Hirata; N Nagata; M Kuwano; H Itoh
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

6.  Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.

Authors:  T J Liang; A E Reid; R Xavier; R D Cardiff; T C Wang
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

7.  Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

Authors:  Gang Zeng; Udayan Apte; Amanda Micsenyi; Aaron Bell; Satdarshan P S Monga
Journal:  Exp Cell Res       Date:  2006-08-10       Impact factor: 3.905

8.  Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.

Authors:  S Rong; S Segal; M Anver; J H Resau; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 9.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway.

Authors:  Mingjiang Li; Xin Yi; Lele Ma; Yanli Zhou
Journal:  Exp Ther Med       Date:  2013-08-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.